Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

World Rank (Aug-2026)
1882
Market Cap (Aug-2026)
12.238 Billion USD
World Rank (Jan-05-2024)
3,718
Market Cap (Jan-05-2024)
3.710 Billion USD
World Rank (Jul-30-2023)
3,705
Market Cap (Jul-30-2023)
3.755 Billion USD
World Rank (Jan-07-2022)
2,778
Market Cap (Jan-07-2022)
6.162 Billion USD
World Rank (Jan-01-2021)
2,029
Market Cap (Jan-01-2021)
7.885 Billion USD
Headquarters Country
USA
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Top Bio Pharmaceutical Companies in USA
Nasdaq / NYSE Code
ARWR
Employee Count
232
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
829 Million USD
Annual Operating Income in USD
98 Million USD
Annual Net Income in USD
-2 Million USD
Annual Results for Period Ending
For year ending September-2025
Total Assets in USD
1,385 Million USD
Total Liabilities in USD
882 Million USD
Total Equity in USD
503 Million USD
Balance Sheet for Period Ending
As of September-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biopharmaceutical
Biotechnology
Company Website
ARROWHEAD PHARMACEUTICALS INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Bio-pharmaceutical company with headquarters is in California, USA.

Annual Results Summary

ARROWHEAD PHARMACEUTICALS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Sep-2023240-205 (Loss)-205 (Loss)
Sep-2022243-178 (Loss)-176 (Loss)
Sep-2021138-149 (Loss)-140 (Loss)
Sep-202087-93 (Loss)-84 (Loss)
Sep-201916861 (Loss)-67 (Loss)
Sep-201816-55 (Loss)-54 (Loss)
Balance Sheet Summary

Total Assets as on Sep-2023 was 765 Million USD.

Total Liabilities as on Sep-2023 was 478 Million USD.

Total Equity as on Sep-2023 was 287 Million USD.

Founded Year
1989
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share